Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. reports developments across flavors, fragrances, food ingredients, health and biosciences for customers in food, beverage, personal care, home care, pet health and related markets. News frequently covers ingredient innovation, application labs and natural-extraction capabilities, including vanilla work in Madagascar and LMR Naturals in perfumery, cosmetics and flavors.
Company updates also address probiotics and bioscience products such as HOWARU Pet and PureStrong, nutrition claims tied to soy protein, quarterly earnings releases, dividends, and other capital or financial disclosures.
IFF (NYSE: IFF) reported second quarter 2026 results on a continuing-operations basis, with net sales of $1.95 billion, up 2% year over year, and adjusted operating EBITDA of $408 million, implying a 20.9% margin and 6% comparable currency-neutral EBITDA growth. Adjusted EPS excluding amortization was $0.82. All three core segments grew on a comparable currency-neutral basis: Taste sales +4%, Health & Biosciences +5%, and Scent +8%.
For the first six months, sales were $3.86 billion and adjusted operating EBITDA $841 million. Free cash flow reached $378 million, up $284 million year over year. IFF highlighted net debt to credit-adjusted EBITDA of 2.5x.
The company detailed its portfolio reshaping, including the previously announced sale of its Food Ingredients disposal group to CVC Capital Partners for approximately $3.8 billion in expected net cash proceeds, with closing targeted by the end of Q2 2027 and IFF retaining about a 10% minority stake. IFF expects about $100 million of stranded costs after closing and plans to eliminate roughly two thirds within one year and substantially all within two years.
IFF’s board approved an enhanced $2.5 billion share repurchase authorization, including about $400 million remaining from a prior program. This includes a $500 million accelerated share repurchase in the second half of 2026 and an additional $2.0 billion in buybacks expected after the Food Ingredients transaction closes, with completion targeted by the end of 2027. IFF intends to use more than $1 billion of net divestiture proceeds to reduce debt.
On a continuing-operations basis, IFF issued 2026 guidance for sales of $7.4–$7.6 billion and adjusted operating EBITDA of $1.53–$1.60 billion, excluding about $3.2 billion of sales and $520 million of adjusted EBITDA from discontinued operations. The company expects comparable currency-neutral sales growth of 2%–4% and comparable currency-neutral adjusted operating EBITDA growth of 4%–8%, with foreign exchange projected to contribute about 1 percentage point to sales growth and 2 percentage points to adjusted EBITDA growth in 2026.
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share on its common stock. The dividend is payable on October 9, 2026 to shareholders of record as of September 18, 2026. The company describes itself as a global leader in flavors, fragrances, and health and biosciences.
SuanNutra, a Carbyne Equity Partners portfolio company, has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The acquired operations will be merged with SuanNutra to form an enlarged global group focused on science-backed natural ingredients.
The combined business will offer clinically supported branded ingredients, botanical extraction at source, fermented vitamins and minerals, and plant-derived natural colours, antioxidants and flavours. The group will have around 700 employees, serving more than 1,200 customers in over 60 countries, with manufacturing across Spain, Slovenia, Peru and the United States. Completion is targeted by the end of 2026, subject to regulatory clearances and customary conditions.
IFF (NYSE: IFF) announced an agreement to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, including natural colors, antioxidants and certain localized flavor activities in Peru, to SuanNutra, a Carbyne Equity Partners portfolio company.
The portfolio generated approximately $170 million in 2025 revenue, employs about 600 people, and operates across five manufacturing facilities in Europe, the United States and Latin America. Financial terms were not disclosed. The companies expect to close the transaction by the end of 2026, subject to customary regulatory clearances and consultation requirements. IFF said the divestiture supports its focus on its core Taste, Scent and Health & Biosciences businesses.
IFF (NYSE:IFF) will release its second quarter 2026 earnings results after market close on Tuesday, August 4, 2026. Management will host a live webcast on Wednesday, August 5, 2026 at 9:00 a.m. ET to discuss results and outlook with investors.
The webcast, slides and replay will be available on ir.iff.com.
IFF (NYSE: IFF) launched SENSORA™, a patent-pending, light-activated pro-fragrance technology platform for home, fabric and personal care. The system enables controlled, phased scent release, sustaining fragrance for days, reportedly up to 20 days, and revealing new olfactive facets over time.
The first application, Floral Fusion, targets liquid detergents, delivering long-lasting floral notes on dry fabrics. According to IFF, SENSORA™ aligns with survey findings that many consumers want longer-lasting laundry fragrance and integrates into its SCENT+™ innovation pillar as a scalable platform.
IFF (NYSE:IFF) and ISIPCA are marking 10 years of their accredited master’s-level Scent Design and Creation program. Launched in 2016, it has trained over 180 professionals from 40 countries, produced 130 graduates, and reports a 100% job placement rate within six months.
IFF (NYSE:IFF) released its 2025 Do More Good Report, showcasing nature-based innovation and sustainability progress across four pillars: Conscious Sourcing, Intentional Innovation, Operating for the Future and Partnerships of Impact.
Highlights include 27.2 million metric tons CO₂e emissions avoided, strong sustainable product innovation, certified natural ingredients and improved safety performance.
IFF (NYSE:IFF) agreed to sell its Food Ingredients business to funds advised by CVC for an enterprise value of about $4.3 billion, roughly 10x EBITDA. IFF will retain a 10% stake (~$200 million). Net cash proceeds of about $3.8 billion will fund debt reduction, share repurchases and core growth.
The divested unit generated nearly $3.1 billion sales and about $430 million EBITDA in 2025. The deal is expected to close by end of Q2 2027 and be initially dilutive to adjusted EPS, while IFF reiterates its 2026 sales and EBITDA guidance.
IFF (NYSE:IFF) inaugurated its new 1.8-hectare experimental field, Domaine des Naturels LMR, in Grasse, France. The site focuses on research in natural ingredients, conservation of local agricultural heritage and education in naturals.
The field integrates agronomy, extraction and perfumery, supports biodiversity and water management, and will host the LMR Naturals Academy for hands-on training, linking Grasse to IFF’s global innovation network.